To further validate the specific CRC signature of KMT2Ar leukemia, we analyzed patterns of TF expression in BeatAML, a large data set of 510 genetically annotated and mRNA-sequenced primary AMLs (Tyner et al. 2018). This evidence concerns the gene TF and leukemia.